hs-10352
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 8, 2020 (NCT04631835)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06788197 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2025 | Henan Medical University |
| NCT05504213 | Phase 1 | Jan 12, 2022 | Fudan University, Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| NCT04631835 | Phase 1 | Sep 8, 2020 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 1 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Henan Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1